QuantumCyte is a technology platform company developing automated microdissection solutions for molecular pathology.
QuantumCyte has raised $1.1M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
QuantumCyte's investors include SOSV, IndieBio, North South Ventures, Gyan Kapur.
QuantumCyte is headquartered in Sunnyvale, United States.
QuantumCyte is a technology platform company developing automated microdissection solutions for molecular pathology.
QuantumCyte is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QuantumCyte — Funding & Investors." VCBacked, August 15, 2023, https://www.vcbacked.co/company/quantumcyte. Accessed October 30, 2026.
VCBacked. (2023). QuantumCyte — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/quantumcyte
{{cite web |title=QuantumCyte — Funding & Investors |url=https://www.vcbacked.co/company/quantumcyte |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated